Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy
PLoS ONE - United States
doi 10.1371/journal.pone.0180628
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 5, 2017
Authors
Publisher
Public Library of Science (PLoS)